Pembrolizumab,Lenvatinib,Sunitinib,Everolimus,Ipilimumab
Merck,Pfizer,eisai,BMS
[' ipi ', 'pembro', 'lenva']
disappointing pfs and os tails of the curves of pembro plus tki (axi or lenva). not durable efficacy. should we keep pembro after 2 years? ipi is mandatory? many questions remained #asco23 
Scientific Committee Member LACOG - GU. Medical Oncologist at Hospital Albert Einstein and CPO. Owner and founder BIO. Following or RT does not mean endorsement